Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001140361-23-004732

EVP & Chief Financial Officer sold 5,389 shares at $1.66 ($8,946)

From the SEC's structured data for this filing

Trades in this filing

Schorno Dean L · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-02 Sale : show line 1 in the form −5,389 $1.66 $8,946 196,519 D
Open-market sales · 5,389 sh · avg $1.66 · $8,946
Loading xslF345X03/form4.xml…